The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. A variety of strategies are employed maximize antibody titer, such Recombinant Antibody as process parameter optimization, media optimization, and adoption of perfusion systems. Fine-tuning